Join to View Full Profile
1275 York AveNew York, NY 10065
Phone+1 212-639-2000
Dr. Sfakianos is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Urologic Surgical Oncology, 2012 - 2014
SUNY Downstate Health Sciences UniversityResidency, Urology, 2008 - 2012- SUNY Downstate Health Sciences UniversityInternship, Transitional Year, 2007 - 2008
Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 2007
Certifications & Licensure
NY State Medical License 2012 - 2027
American Board of Urology Urology
Publications & Presentations
PubMed
- Novel bioabsorbable, low-dose rate brachytherapy device (CivaSheet) with radical prostatectomy and adjuvant external beam radiation for the management of prostate cancer.Kennedy E Okhawere, Shirin Razdan, Alp Tuna Beksac, Indu Saini, Laura Zuluaga
BJU International. 2025-05-01 - Efficacy of Bacillus Calmette-Guérin compared to sequential gemcitabine and docetaxel in Ta high-grade non-muscle invasive bladder cancer.Ahmed Eraky, Brenda Hug, Reuben Ben-David, Kaushik P Kolanukuduru, Nikhil Waingankar
World Journal of Urology. 2025-04-28 - 5 citationsAssociation of Tumor-informed Circulating Tumor DNA Detectability Before and After Radical Cystectomy with Disease-free Survival in Patients with Bladder Cancer.John P Sfakianos, Arnab Basu, George Laliotis, Shivaram Cumarasamy, Jordan M Rich
European Urology Oncology. 2025-04-01
Journal Articles
- An Evaluation of Race, Ethnicity, Age, and Sex-Based Representation in Phase I to II Renal Cell Carcinoma Clinical Trials in the United StatesIsuru Jayaratna, John P Sfakianos, Ketan K Badani, Urologic Oncology
Authored Content
- An Evaluation of Race, Ethnicity, Age, and Sex-Based Representation in Phase I to II Renal Cell Carcinoma Clinical Trials in the United StatesJune 2018
Press Mentions
New Approaches in the Bladder-Sparing ParadigmMarch 20th, 2023- Ask the Expert: John Sfakianos, M.D.June 17th, 2021
- Novel Immune Checkpoint Axis to Understand BCG Resistance and Improve Treatment in Non-Muscle Invasive Bladder Cancer - Amir Horowitz & John SfakianosMay 10th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
